In the present study, we aimed to analyze VISTA expression within the tumor microenvironment of UM patients, to examine its association with clinicopathological features, to evaluate its prognostic factor, and to correlate it with PD1 and CTLA-4, two immune checkpoints already studied in UM pathology. Here, VSIR is linked to neoplasm.